Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
{{familytree | | | | | | | | | |!| | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | }} | ||
{{familytree | | | | | | | | | C01 | | | | | |C01=Histopathologic examination}} | {{familytree | | | | | | | | | C01 | | | | | |C01=Histopathologic examination}} | ||
{{familytree | | |,|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }} | {{familytree | | |,|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }} | ||
{{familytree | |D01| | | | | |D02| | | | D03 |D01='''Squamous cell carcinoma'''|D02='''Adenocarcinoma and poorly differntiated carcinoma'''|D03='''Neuroendocrine carcinoma'''}} | {{familytree | |D01| | | | | |D02| | | | D03 |D01='''Squamous cell carcinoma'''|D02='''Adenocarcinoma and poorly differntiated carcinoma'''|D03='''Neuroendocrine carcinoma'''}} | ||
{{familytree | | |!| | | | | | | | |!| | | | |!| }} | {{familytree | | |!| | | | | | | | |!| | | | |!| }} | ||
{{familytree | |E01| | | | | | |E02 | | | | {{familytree | |E01| | | | | | |E02 | | | |E03| |E01=Additional tests specific to location of metastasis|E02=Gender specific tests|E03=• Octreoscan<br> • Plasma chromogranin A}} | ||
{{familytree |,|-|^|-|.| | | | |!| | | | | | | | }} | {{familytree |,|-|^|-|.| | | | |!| | | | | | | | }} | ||
{{familytree |F01| |F02| |F03| | | | |!| | | | | |}} | {{familytree |F01| |F02| |F03| | | | |!| | | | | |}} | ||
Revision as of 18:52, 10 October 2018
| Tumor of unknown primary origin | |||||||||||||||||||||||||||||||||||||||||||
| • Full medical history and physical exam • Basic blood and bichemical analysis • CT scan of chest, abdomen, and pelvis | |||||||||||||||||||||||||||||||||||||||||||
| Histopathologic examination | |||||||||||||||||||||||||||||||||||||||||||
| Squamous cell carcinoma | Adenocarcinoma and poorly differntiated carcinoma | Neuroendocrine carcinoma | |||||||||||||||||||||||||||||||||||||||||
| Additional tests specific to location of metastasis | Gender specific tests | • Octreoscan • Plasma chromogranin A | |||||||||||||||||||||||||||||||||||||||||
| {{{F01}}} | {{{F02}}} | {{{F03}}} | |||||||||||||||||||||||||||||||||||||||||
| Male • PSA • aFP • BHCG | Female • Mammography • Ultrasound or pelvic CT | ||||||||||||||||||||||||||||||||||||||||||